Global Antibody and Recombinant Protein CDMO Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibody and Recombinant Protein CDMO Market Size 2017-2028

2.1.2 Antibody and Recombinant Protein CDMO Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Antibody and Recombinant Protein CDMO Segment by Type

2.2.1 Antibody CDMO

2.2.2 Recombinant Protein CDMO

2.3 Antibody and Recombinant Protein CDMO Market Size by Type

2.3.1 Antibody and Recombinant Protein CDMO Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

2.4 Antibody and Recombinant Protein CDMO Segment by Application

2.4.1 Pharmaceutical Company

2.4.2 Biotechnology Company

2.4.3 Generic Company

2.5 Antibody and Recombinant Protein CDMO Market Size by Application

2.5.1 Antibody and Recombinant Protein CDMO Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

3 Antibody and Recombinant Protein CDMO Market Size by Player

3.1 Antibody and Recombinant Protein CDMO Market Size Market Share by Players

3.1.1 Global Antibody and Recombinant Protein CDMO Revenue by Players (2020-2022)

3.1.2 Global Antibody and Recombinant Protein CDMO Revenue Market Share by Players (2020-2022)

3.2 Global Antibody and Recombinant Protein CDMO Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Antibody and Recombinant Protein CDMO by Regions

4.1 Antibody and Recombinant Protein CDMO Market Size by Regions (2017-2022)

4.2 Americas Antibody and Recombinant Protein CDMO Market Size Growth (2017-2022)

4.3 APAC Antibody and Recombinant Protein CDMO Market Size Growth (2017-2022)

4.4 Europe Antibody and Recombinant Protein CDMO Market Size Growth (2017-2022)

4.5 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Growth (2017-2022)

5 Americas

5.1 Americas Antibody and Recombinant Protein CDMO Market Size by Country (2017-2022)

5.2 Americas Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022)

5.3 Americas Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibody and Recombinant Protein CDMO Market Size by Region (2017-2022)

6.2 APAC Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022)

6.3 APAC Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Antibody and Recombinant Protein CDMO by Country (2017-2022)

7.2 Europe Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022)

7.3 Europe Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibody and Recombinant Protein CDMO by Region (2017-2022)

8.2 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022)

8.3 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Antibody and Recombinant Protein CDMO Market Forecast

10.1 Global Antibody and Recombinant Protein CDMO Forecast by Regions (2023-2028)

10.1.1 Global Antibody and Recombinant Protein CDMO Forecast by Regions (2023-2028)

10.1.2 Americas Antibody and Recombinant Protein CDMO Forecast

10.1.3 APAC Antibody and Recombinant Protein CDMO Forecast

10.1.4 Europe Antibody and Recombinant Protein CDMO Forecast

10.1.5 Middle East & Africa Antibody and Recombinant Protein CDMO Forecast

10.2 Americas Antibody and Recombinant Protein CDMO Forecast by Country (2023-2028)

10.2.1 United States Antibody and Recombinant Protein CDMO Market Forecast

10.2.2 Canada Antibody and Recombinant Protein CDMO Market Forecast

10.2.3 Mexico Antibody and Recombinant Protein CDMO Market Forecast

10.2.4 Brazil Antibody and Recombinant Protein CDMO Market Forecast

10.3 APAC Antibody and Recombinant Protein CDMO Forecast by Region (2023-2028)

10.3.1 China Antibody and Recombinant Protein CDMO Market Forecast

10.3.2 Japan Antibody and Recombinant Protein CDMO Market Forecast

10.3.3 Korea Antibody and Recombinant Protein CDMO Market Forecast

10.3.4 Southeast Asia Antibody and Recombinant Protein CDMO Market Forecast

10.3.5 India Antibody and Recombinant Protein CDMO Market Forecast

10.3.6 Australia Antibody and Recombinant Protein CDMO Market Forecast

10.4 Europe Antibody and Recombinant Protein CDMO Forecast by Country (2023-2028)

10.4.1 Germany Antibody and Recombinant Protein CDMO Market Forecast

10.4.2 France Antibody and Recombinant Protein CDMO Market Forecast

10.4.3 UK Antibody and Recombinant Protein CDMO Market Forecast

10.4.4 Italy Antibody and Recombinant Protein CDMO Market Forecast

10.4.5 Russia Antibody and Recombinant Protein CDMO Market Forecast

10.5 Middle East & Africa Antibody and Recombinant Protein CDMO Forecast by Region (2023-2028)

10.5.1 Egypt Antibody and Recombinant Protein CDMO Market Forecast

10.5.2 South Africa Antibody and Recombinant Protein CDMO Market Forecast

10.5.3 Israel Antibody and Recombinant Protein CDMO Market Forecast

10.5.4 Turkey Antibody and Recombinant Protein CDMO Market Forecast

10.5.5 GCC Countries Antibody and Recombinant Protein CDMO Market Forecast

10.6 Global Antibody and Recombinant Protein CDMO Forecast by Type (2023-2028)

10.7 Global Antibody and Recombinant Protein CDMO Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Batavia Biosciences

11.1.1 Batavia Biosciences Company Information

11.1.2 Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offered

11.1.3 Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Batavia Biosciences Main Business Overview

11.1.5 Batavia Biosciences Latest Developments

11.2 Grifols

11.2.1 Grifols Company Information

11.2.2 Grifols Antibody and Recombinant Protein CDMO Product Offered

11.2.3 Grifols Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Grifols Main Business Overview

11.2.5 Grifols Latest Developments

11.3 Cerbios-Pharma SA

11.3.1 Cerbios-Pharma SA Company Information

11.3.2 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered

11.3.3 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Cerbios-Pharma SA Main Business Overview

11.3.5 Cerbios-Pharma SA Latest Developments

11.4 HALIX

11.4.1 HALIX Company Information

11.4.2 HALIX Antibody and Recombinant Protein CDMO Product Offered

11.4.3 HALIX Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 HALIX Main Business Overview

11.4.5 HALIX Latest Developments

11.5 Biovian Oy

11.5.1 Biovian Oy Company Information

11.5.2 Biovian Oy Antibody and Recombinant Protein CDMO Product Offered

11.5.3 Biovian Oy Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Biovian Oy Main Business Overview

11.5.5 Biovian Oy Latest Developments

11.6 Catalent

11.6.1 Catalent Company Information

11.6.2 Catalent Antibody and Recombinant Protein CDMO Product Offered

11.6.3 Catalent Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Catalent Main Business Overview

11.6.5 Catalent Latest Developments

11.7 Goodwin Biotechnology

11.7.1 Goodwin Biotechnology Company Information

11.7.2 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offered

11.7.3 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Goodwin Biotechnology Main Business Overview

11.7.5 Goodwin Biotechnology Latest Developments

11.8 Merck

11.8.1 Merck Company Information

11.8.2 Merck Antibody and Recombinant Protein CDMO Product Offered

11.8.3 Merck Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Merck Main Business Overview

11.8.5 Merck Latest Developments

11.9 Hangzhou Hs-biopharm

11.9.1 Hangzhou Hs-biopharm Company Information

11.9.2 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offered

11.9.3 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Hangzhou Hs-biopharm Main Business Overview

11.9.5 Hangzhou Hs-biopharm Latest Developments

11.10 Wuxibiologics

11.10.1 Wuxibiologics Company Information

11.10.2 Wuxibiologics Antibody and Recombinant Protein CDMO Product Offered

11.10.3 Wuxibiologics Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Wuxibiologics Main Business Overview

11.10.5 Wuxibiologics Latest Developments

11.11 Bioinnobio

11.11.1 Bioinnobio Company Information

11.11.2 Bioinnobio Antibody and Recombinant Protein CDMO Product Offered

11.11.3 Bioinnobio Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Bioinnobio Main Business Overview

11.11.5 Bioinnobio Latest Developments

11.12 Thousand Oaks Biopharmaceuticals

11.12.1 Thousand Oaks Biopharmaceuticals Company Information

11.12.2 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offered

11.12.3 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Thousand Oaks Biopharmaceuticals Main Business Overview

11.12.5 Thousand Oaks Biopharmaceuticals Latest Developments

11.13 Cerbios-Pharma SA

11.13.1 Cerbios-Pharma SA Company Information

11.13.2 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered

11.13.3 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Cerbios-Pharma SA Main Business Overview

11.13.5 Cerbios-Pharma SA Latest Developments

11.14 Eurogentec

11.14.1 Eurogentec Company Information

11.14.2 Eurogentec Antibody and Recombinant Protein CDMO Product Offered

11.14.3 Eurogentec Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Eurogentec Main Business Overview

11.14.5 Eurogentec Latest Developments

11.15 HJB

11.15.1 HJB Company Information

11.15.2 HJB Antibody and Recombinant Protein CDMO Product Offered

11.15.3 HJB Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 HJB Main Business Overview

11.15.5 HJB Latest Developments

11.16 Bibo Pharma

11.16.1 Bibo Pharma Company Information

11.16.2 Bibo Pharma Antibody and Recombinant Protein CDMO Product Offered

11.16.3 Bibo Pharma Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Bibo Pharma Main Business Overview

11.16.5 Bibo Pharma Latest Developments

11.17 MabPlex International

11.17.1 MabPlex International Company Information

11.17.2 MabPlex International Antibody and Recombinant Protein CDMO Product Offered

11.17.3 MabPlex International Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 MabPlex International Main Business Overview

11.17.5 MabPlex International Latest Developments

11.18 Genscriptprobio

11.18.1 Genscriptprobio Company Information

11.18.2 Genscriptprobio Antibody and Recombinant Protein CDMO Product Offered

11.18.3 Genscriptprobio Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Genscriptprobio Main Business Overview

11.18.5 Genscriptprobio Latest Developments

11.19 Vetter

11.19.1 Vetter Company Information

11.19.2 Vetter Antibody and Recombinant Protein CDMO Product Offered

11.19.3 Vetter Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Vetter Main Business Overview

11.19.5 Vetter Latest Developments

11.20 Etinpro (Beijing) Co

11.20.1 Etinpro (Beijing) Co Company Information

11.20.2 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offered

11.20.3 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Etinpro (Beijing) Co Main Business Overview

11.20.5 Etinpro (Beijing) Co Latest Developments

11.21 Boehringer Ingelheim BioXcellence

11.21.1 Boehringer Ingelheim BioXcellence Company Information

11.21.2 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offered

11.21.3 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 Boehringer Ingelheim BioXcellence Main Business Overview

11.21.5 Boehringer Ingelheim BioXcellence Latest Developments

11.22 Lonza

11.22.1 Lonza Company Information

11.22.2 Lonza Antibody and Recombinant Protein CDMO Product Offered

11.22.3 Lonza Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.22.4 Lonza Main Business Overview

11.22.5 Lonza Latest Developments

11.23 3SBio Inc

11.23.1 3SBio Inc Company Information

11.23.2 3SBio Inc Antibody and Recombinant Protein CDMO Product Offered

11.23.3 3SBio Inc Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.23.4 3SBio Inc Main Business Overview

11.23.5 3SBio Inc Latest Developments

11.24 Porton

11.24.1 Porton Company Information

11.24.2 Porton Antibody and Recombinant Protein CDMO Product Offered

11.24.3 Porton Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2020-2022)

11.24.4 Porton Main Business Overview

11.24.5 Porton Latest Developments

12 Research Findings and Conclusion

Table 1. Antibody and Recombinant Protein CDMO Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antibody CDMO

Table 3. Major Players of Recombinant Protein CDMO

Table 4. Antibody and Recombinant Protein CDMO Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

Table 7. Antibody and Recombinant Protein CDMO Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

Table 10. Global Antibody and Recombinant Protein CDMO Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Antibody and Recombinant Protein CDMO Revenue Market Share by Player (2020-2022)

Table 12. Antibody and Recombinant Protein CDMO Key Players Head office and Products Offered

Table 13. Antibody and Recombinant Protein CDMO Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Antibody and Recombinant Protein CDMO Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Regions (2017-2022)

Table 18. Americas Antibody and Recombinant Protein CDMO Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Country (2017-2022)

Table 20. Americas Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

Table 22. Americas Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

Table 24. APAC Antibody and Recombinant Protein CDMO Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Region (2017-2022)

Table 26. APAC Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

Table 28. APAC Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

Table 30. Europe Antibody and Recombinant Protein CDMO Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Country (2017-2022)

Table 32. Europe Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

Table 34. Europe Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Antibody and Recombinant Protein CDMO

Table 43. Key Market Challenges & Risks of Antibody and Recombinant Protein CDMO

Table 44. Key Industry Trends of Antibody and Recombinant Protein CDMO

Table 45. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Application (2023-2028)

Table 51. Batavia Biosciences Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 52. Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offered

Table 53. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Batavia Biosciences Main Business

Table 55. Batavia Biosciences Latest Developments

Table 56. Grifols Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 57. Grifols Antibody and Recombinant Protein CDMO Product Offered

Table 58. Grifols Main Business

Table 59. Grifols Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Grifols Latest Developments

Table 61. Cerbios-Pharma SA Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 62. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered

Table 63. Cerbios-Pharma SA Main Business

Table 64. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Cerbios-Pharma SA Latest Developments

Table 66. HALIX Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 67. HALIX Antibody and Recombinant Protein CDMO Product Offered

Table 68. HALIX Main Business

Table 69. HALIX Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. HALIX Latest Developments

Table 71. Biovian Oy Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 72. Biovian Oy Antibody and Recombinant Protein CDMO Product Offered

Table 73. Biovian Oy Main Business

Table 74. Biovian Oy Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Biovian Oy Latest Developments

Table 76. Catalent Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 77. Catalent Antibody and Recombinant Protein CDMO Product Offered

Table 78. Catalent Main Business

Table 79. Catalent Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Catalent Latest Developments

Table 81. Goodwin Biotechnology Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 82. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offered

Table 83. Goodwin Biotechnology Main Business

Table 84. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Goodwin Biotechnology Latest Developments

Table 86. Merck Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 87. Merck Antibody and Recombinant Protein CDMO Product Offered

Table 88. Merck Main Business

Table 89. Merck Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Merck Latest Developments

Table 91. Hangzhou Hs-biopharm Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 92. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offered

Table 93. Hangzhou Hs-biopharm Main Business

Table 94. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Hangzhou Hs-biopharm Latest Developments

Table 96. Wuxibiologics Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 97. Wuxibiologics Antibody and Recombinant Protein CDMO Product Offered

Table 98. Wuxibiologics Main Business

Table 99. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Wuxibiologics Latest Developments

Table 101. Bioinnobio Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 102. Bioinnobio Antibody and Recombinant Protein CDMO Product Offered

Table 103. Bioinnobio Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Bioinnobio Main Business

Table 105. Bioinnobio Latest Developments

Table 106. Thousand Oaks Biopharmaceuticals Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 107. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offered

Table 108. Thousand Oaks Biopharmaceuticals Main Business

Table 109. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Thousand Oaks Biopharmaceuticals Latest Developments

Table 111. Cerbios-Pharma SA Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 112. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered

Table 113. Cerbios-Pharma SA Main Business

Table 114. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Cerbios-Pharma SA Latest Developments

Table 116. Eurogentec Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 117. Eurogentec Antibody and Recombinant Protein CDMO Product Offered

Table 118. Eurogentec Main Business

Table 119. Eurogentec Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Eurogentec Latest Developments

Table 121. HJB Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 122. HJB Antibody and Recombinant Protein CDMO Product Offered

Table 123. HJB Main Business

Table 124. HJB Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. HJB Latest Developments

Table 126. Bibo Pharma Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 127. Bibo Pharma Antibody and Recombinant Protein CDMO Product Offered

Table 128. Bibo Pharma Main Business

Table 129. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Bibo Pharma Latest Developments

Table 131. MabPlex International Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 132. MabPlex International Antibody and Recombinant Protein CDMO Product Offered

Table 133. MabPlex International Main Business

Table 134. MabPlex International Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. MabPlex International Latest Developments

Table 136. Genscriptprobio Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 137. Genscriptprobio Antibody and Recombinant Protein CDMO Product Offered

Table 138. Genscriptprobio Main Business

Table 139. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 140. Genscriptprobio Latest Developments

Table 141. Vetter Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 142. Vetter Antibody and Recombinant Protein CDMO Product Offered

Table 143. Vetter Main Business

Table 144. Vetter Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 145. Vetter Latest Developments

Table 146. Etinpro (Beijing) Co Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 147. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offered

Table 148. Etinpro (Beijing) Co Main Business

Table 149. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 150. Etinpro (Beijing) Co Latest Developments

Table 151. Boehringer Ingelheim BioXcellence Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 152. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offered

Table 153. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 154. Boehringer Ingelheim BioXcellence Main Business

Table 155. Boehringer Ingelheim BioXcellence Latest Developments

Table 156. Lonza Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 157. Lonza Antibody and Recombinant Protein CDMO Product Offered

Table 158. Lonza Main Business

Table 159. Lonza Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 160. Lonza Latest Developments

Table 161. 3SBio Inc Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 162. 3SBio Inc Antibody and Recombinant Protein CDMO Product Offered

Table 163. 3SBio Inc Main Business

Table 164. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 165. 3SBio Inc Latest Developments

Table 166. Porton Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors

Table 167. Porton Antibody and Recombinant Protein CDMO Product Offered

Table 168. Porton Main Business

Table 169. Porton Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 170. Porton Latest Developments

List of Figures

Figure 1. Antibody and Recombinant Protein CDMO Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Antibody and Recombinant Protein CDMO Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type in 2021

Figure 7. Antibody and Recombinant Protein CDMO in Pharmaceutical Company

Figure 8. Global Antibody and Recombinant Protein CDMO Market: Pharmaceutical Company (2017-2022) & ($ Millions)

Figure 9. Antibody and Recombinant Protein CDMO in Biotechnology Company

Figure 10. Global Antibody and Recombinant Protein CDMO Market: Biotechnology Company (2017-2022) & ($ Millions)

Figure 11. Antibody and Recombinant Protein CDMO in Generic Company

Figure 12. Global Antibody and Recombinant Protein CDMO Market: Generic Company (2017-2022) & ($ Millions)

Figure 13. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2021

Figure 14. Global Antibody and Recombinant Protein CDMO Revenue Market Share by Player in 2021

Figure 15. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Antibody and Recombinant Protein CDMO Market Size 2017-2022 ($ Millions)

Figure 17. APAC Antibody and Recombinant Protein CDMO Market Size 2017-2022 ($ Millions)

Figure 18. Europe Antibody and Recombinant Protein CDMO Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size 2017-2022 ($ Millions)

Figure 20. Americas Antibody and Recombinant Protein CDMO Value Market Share by Country in 2021

Figure 21. Americas Antibody and Recombinant Protein CDMO Consumption Market Share by Type in 2021

Figure 22. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2021

Figure 23. United States Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Region in 2021

Figure 28. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2021

Figure 29. China Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Country in 2021

Figure 36. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Type in 2021

Figure 37. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2021

Figure 38. Germany Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2021

Figure 46. Egypt Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Antibody and Recombinant Protein CDMO Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 52. APAC Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 53. Europe Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 55. United States Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 56. Canada Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 59. China Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 60. Japan Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 61. Korea Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 63. India Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 64. Australia Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 65. Germany Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 66. France Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 67. UK Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 68. Italy Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 69. Russia Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 70. Spain Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 73. Israel Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Antibody and Recombinant Protein CDMO Market Size 2023-2028 ($ Millions)